Folic acid intake reduces the risk of neural tube defects (NTDs). Although the 677C-*T mutation in the 5,1O-methylenetetrahydrofoIate reductase (MTHFR) gene is a risk factor for NTDs, it only partly explains the elevated homocysteine levels in mothers of children with NTDs. We measured vitamin B12, folate and homocysteine in patients with spina bifida (SB), their parents, and in controls, to investigate which other enzymes of homocysteine metabolism might be defective. Because homozygosity for the 677C-+T mutation causes decreased plasma folate and increased red-cell folate (RCF) and plasma homo cysteine levels, we excluded individuals homozygous for that mutation. The remaining SB patients and their parents still had lowered plasma folate and elevated total homocysteine levels, and a small subset had decreased vitamin B12 levels. Red-cell folate was the same in all groups, suggesting that dietary folate intake and its uptake was normal. Risk of SB was increased at the 25th percentile of plasma folate and at the 75th percentile of homocysteine values in SB patients and their parents, and at the 5th and 25th percentiles of vitamin B12 in mothers with SB-affected offspring. This underlines the functional importance o f homocysteine remethylation to methionine. There was no correlation between vitamin B12 and homo cysteine or RCF. In combination with the lowered plasma folate (80-90% 5-methyltetrahydrofolate), our data do not support a major involvement of methionine synthase in the aetiology of SB. Our data rather favour the involvement of genetic variation at loci coding for the formation of 5-methyltetrahy drofolate, such as MTHFR, methylenetetrahydrofolate dehydrogenase or serine hydroxymethyltransferase. O Oxford University Press 1997 506 N M .J. van der Put et al.
Introduction
Neural tube defects (NTDs) can arise from incom plete closure of the cranial part of the neural tube, resulting in anencephaly, or imperfect closure of the caudal part of the neural tube, resulting in spina bifida (SB). The clinical expression of this disability varies from mild to very severe abnormal-ities, which can be lethal. The aetiology of NTD is considered to be multifactorial, i.e. the com bined action of defective genes and nutritional factors.
Recently, our group identified the first genetic risk factor for S B ,1 i.e. the 677C->T mutation in the 5,10-methylenetetrahydrofolate reductase (M THFR) gene. These findings were confirmed by others.2 M TH FR catalyzes the formation of methyltetrahydrofolate, which is a substrate in the homocys teine remethylation to methionine (Figure 1) , Homozygosity for the 677C-*T mutation results in elevated homocysteine levels and a redistribution of folates, viz. elevated red-cell folate (RCF) and lowered plasma folate levels. 1 Periconceptional folate administration reduces the NTD birth prevalence by 60-10 0 % .3"8 Although the biochemical effects of the 677C-»T mutation can be corrected by folate therapy, this mutation can account at the most (after combining the genotype of the mother and child) for 2 5 % of the observed protective effect of folate. 1, 9 Other defective enzymes may thus be present in the folate-dependent homo cysteine metabolism of family members (patients and their parents) with SB offspring.
W e studied the RCF levels and the vitamin B 12, folate and total homocysteine levels in plasma of SB patients and their parents, and compared them to the values in controls. Plasma folate is 80-90% 5-methyltetrahydrofolate, the circulatory form of folate. The other folate derivatives are mainly inside the cell. Abnormal vitamin and homocysteine pat terns could suggest other defective enzymes involved in homocysteine metabolism (i.e. methionine syn thase, methylenetetrahydrofolate or serine hydroxymethyltransferase) in these families with SB offspring, The 677C->-T mutation in the M TH FR gene leads to lowered plasma folate levels and elevated plasma homocysteine levels in individuals homozygous for this mutation,1,9 indicating the plausibility of this present approach. Because these abnormal folate and homocysteine levels would have confounded the present investigation, these individuals were excluded from the study. Heterozygosity for the 677C->T mutation does not affect the homocysteine and folate status of these individuals.1,9 Therefore w e regarded individuals heterozygous for this common mutation and individuals with a 'wild-type' genotype as one group.
Methods
Families with SB offspring (SB patients and their parents) were recruited in collaboration with a Dutch society for patients with central nervous system defects and their parents (BO SK ).1 The study group included 63 mothers (mean age 45.7, + SD 11.7 years); 56 fathers (mean age 47.6 + 11.6 years) and 55 of their children with SB (mean age 23.3 + 11.6 years). Children younger than 3 years were excluded, as were individuals homozygous for the 677C~*T mutation in the M THFR gene. The control group of 95 unrelated Dutch individuals (23 men and 72 women), with no history of SB (mean age 41.0, SD 9.0 years) was recruited by public advertisement. 10'11 The study was approved by the ethics committee, and written informed consent was obtained.
Total homocysteine concentrations were measured in EDTA plasma.12 Folate and vitamin B 12 levels of heparinized plasma, and folate levels in red blood cells, were determined by Dualcount Solid Phase Boil Radio assay (Diagnostic Products).13
Statistics
Because the distribution of the data was skewed, results are expressed as medians + range and as percentiles of the total. Crude odds ratios (O R) and 
Results
Virtually all individual vitamin B 12, RCF, plasma folate and homocysteine levels of patients with SB and their parents were within the normal range. However, the median homocysteine values of patients with SB and their parents were significantly elevated when compared to controls, and the plasma folate levels of the patients and their fathers were significantly lower when compared to controls ( Table 1) . Median plasma vitamin B 12 and RCF levels did not differ from control values. After subdividing into groups with different increasing vitam in and homocysteine levels (Figure 2a -d), some 3 0 -4 5 % of the family members had plasma folate levels belonging to the lowest category of the controls (Figure 2a ). Almost 50-75% of the SB patients and their parents had homocysteine levels w ithin the two highest homocysteine categories of controls ( Figure 2b ). O nly a small subset of the fam ily mem bers had decreased vitamin B12 levels ( Figure 2c ). The distribution of RCF values in fam ilies with SB offspring resembled that in the controls (Figure 2d ).
The 5 % and 2 5 % cut-off points of plasma folate, RCF and vitamin B12 were 7.4 and 11.0 nmol/I, 323 and 415 nmol/I and 127 and 200 pmol/I, respect ively. The 75% and 95% cut-off points of plasma homocysteine were 12.5 and 17.9 |imol/l. Table2 shows the calculated crude ORs for these cut-off points of plasma folate, vitamin B12, and homocyst eine of mothers, fathers and SB patients vs. controls. W e observed a significantly increased risk for SB offspring at the 25th percentile of the plasma folate levels and at the 75th percentile of the plasma homocysteine levels in SB patients and their parents. . At the 5th and 25th percentile of vitamin B12 levels, only mothers of a child with SB showed an increased risk of SB-affected offspring.
To score for associations between the different vitamins and homocysteine levels of family members and controls, we calculated the Spearman correlation coefficients (Table 3) , Plasma folate correlated with RCF and showed an inverse correlation with total plasma homocysteine. There was no correlation between plasma or RCF with vitamin B12. Homocysteine levels of family members showed an inverse correlation with RCF levels. The vitamin B12 levels of SB patients showed an inverse correlation with plasma homocysteine values, and the vitamin B 12 levels of the fathers correlated with the RCF levels. No other correlations were observed.
Discussion
W e examined the levels of vitamin BUf folate and homocysteine in families with SB-affected offspring to elucidate possible alterations in their metabolism. The median plasma homocysteine levels of SB patients and their parents were significantly higher than in controls. SB patients and their fathers had significantly lower median plasma folate levels. This was not observed in the mothers, but after subdivid ing into different categories, the mothers also showed an significantly increased risk of SB-affected offspring at the 25th percentile of plasma folate. The median vitamin B 12 levels were not decreased in SB family members, but after subdividing into different categor ies, the mothers of a child with SB had a increased risk of SB-affected offspring at the 5th and 25th percentiles. These findings support our previous hypothesis of a role for folate-dependent homocyst eine metabolism in the aetiology of S B .13 NTD may partly be caused by nutritional folate deficiencies.14,15 RCF is an indicator for the stored folate derivatives in the cell. Some studies have reported decreased RCF levels in mothers with NTD offspring, indicating a possible nutritional folate defi ciency in these individuals. 16, 17 In our study, the RCF levels of fam ily members were comparable to those of controls, arguing against nutritional folate defi ciency or a defect in folate uptake in our study group. However, families with SB offspring may have higher nutritional folate requirements, due to a defective folate metabolism.15 Especially during preg nancy, a relatively mild biochemical defect in folate metabolism/ requiring a higher nutritional folate intake, may become of major importance. In our study group, additional folate intake would be over coming a metabolic folate deficiency than supple menting a nutritional folate deficiency.
Several studies suggest that methionine synthase (MS) might be involved in the aetiology of N TD . 13,16,ia In the presence of vitamin B 12, MS catalyzes the transmethylation of 5-methyltetrahydrofolate and homocysteine to methionine and tetrahydrofolate (Figure 1 ). Therefore a M S or vitamin B 12 deficiency should theoretically lead to increased plasma folate and plasma homocysteine, and possibly to decreased RCF levels, a combination not observed in the present study. Although a small subset of mothers with SB-affected offspring had decreased vitamin B 12 levels, no correlations with homocysteine or folate were observed. Instead, decreased plasma folate and normal RCF levels were present in patients with SB and their parents. If the availability of vitamin B 12 were inadequate, one would also expect to find a correlation of vitamin B 12 with RCF and an inverse correlation of vitamin B 12 with plasma folate, which was not observed (Table 3) . These findings do not support the presence of reduced M S activity in the aetiology of SB in our study group. may reflect mutations in genes encoding the enzymes involved in the formation of 5-methyltetrahydrofolate. In this respect, next to M THFR, methylenetetrahydrofolate dehydrogenase and serine hydroxymethyl transferase (Figure 1 ) are candidate enzymes.
Vitamin B 12 as a cofactor, and 5-methyltetrahydrofolate as a cosubstrate, are essential for the remethylation of homocysteine to methionine. Methionine can be activated by ATP to Sadenosylmethionine (AdoMet). AdoMet donates its methyl group in over a hundred different methyltransferase-catalyzed reactions, including protein and D N A methyl at ion.20 Thus reduced availability of vitamin B 12 and 5-methyltetrahydrofolate might cause AdoM et depletion. Our study shows the presence of elevated plasma total homocysteine levels in families with SB offspring, correlating with lowered plasma folate levels, indicating a reduced conversion of homocysteine to methionine. W e recently showed that addition of methionine and even homocysteine to cultured rat embryos prevented the development of N T D .21 Both the lowered plasma folate in SB patients and their parents, and the lowered vitamin B 12 levels in mothers with SB-affected offspring observed in the present study, could cause a lowered methionine and AdoMet availability. This in turn may disturb gene expression via reduced DNA methylation and/or other important methylation reac tions in the cells, interfering with the proper closure of the neural tube.
In conclusion, we found increased homocysteine and decreased plasma folate levels in SB patients and their parents, indicating defects in the enzymes involved in the synthesis of 5-methyltetrahydrofolate. Reduced function of M THFR, methylenetetrahydrofolate dehydrogenase and serine hydroxymethyl transferase may be involved in the aetiology of NTDs.
